| urogenital system development | GO:0001655 | 261 | 1.000 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.999 | |
| wnt signaling pathway involved in kidney development | GO:0061289 | 2 | 0.998 | |
| gland development | GO:0048732 | 330 | 0.998 | |
| prostate gland development | GO:0030850 | 48 | 0.998 | |
| seminiferous tubule development | GO:0072520 | 14 | 0.998 | |
| gonad development | GO:0008406 | 141 | 0.997 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.996 | |
| female gonad development | GO:0008585 | 71 | 0.995 | |
| response to peptide hormone | GO:0043434 | 127 | 0.993 | Rat |
| female sex differentiation | GO:0046660 | 84 | 0.990 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.990 | |
| cellular response to gonadotropin stimulus | GO:0071371 | 4 | 0.989 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.989 | |
| kidney development | GO:0001822 | 213 | 0.987 | |
| positive regulation of inositol phosphate biosynthetic process | GO:0060732 | 2 | 0.987 | |
| metanephric glomerulus development | GO:0072224 | 13 | 0.987 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.986 | |
| creatinine metabolic process | GO:0046449 | 3 | 0.985 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.985 | |
| male gonad development | GO:0008584 | 88 | 0.985 | |
| regulation of nucleotide biosynthetic process | GO:0030808 | 34 | 0.984 | |
| camp biosynthetic process | GO:0006171 | 31 | 0.982 | |
| antral ovarian follicle growth | GO:0001547 | 5 | 0.982 | |
| epithelial cell development | GO:0002064 | 159 | 0.982 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.978 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.977 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.976 | |
| steroid metabolic process | GO:0008202 | 119 | 0.976 | |
| multicellular organism growth | GO:0035264 | 161 | 0.973 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.973 | |
| response to testosterone | GO:0033574 | 3 | 0.970 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.969 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.968 | |
| regulation of steroid biosynthetic process | GO:0050810 | 26 | 0.967 | |
| spermatogenesis | GO:0007283 | 284 | 0.966 | |
| response to alcohol | GO:0097305 | 48 | 0.965 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.959 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.958 | |
| cell fate commitment | GO:0045165 | 210 | 0.957 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.953 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.953 | |
| hormone mediated signaling pathway | GO:0009755 | 23 | 0.953 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.950 | |
| synaptic transmission | GO:0007268 | 329 | 0.949 | |
| positive regulation of camp metabolic process | GO:0030816 | 19 | 0.948 | |
| male sex differentiation | GO:0046661 | 109 | 0.947 | |
| renal system development | GO:0072001 | 225 | 0.947 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.945 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.942 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.937 | |
| positive regulation of intracellular steroid hormone receptor signaling pathway | GO:0033145 | 4 | 0.937 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.934 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.934 | |
| steroid hormone mediated signaling pathway | GO:0043401 | 6 | 0.934 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 26 | 0.932 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.927 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.927 | |
| rhythmic process | GO:0048511 | 174 | 0.927 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.926 | |
| negative regulation of triglyceride metabolic process | GO:0090209 | 4 | 0.926 | |
| creatine metabolic process | GO:0006600 | 4 | 0.924 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.922 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.919 | |
| regulation of androgen receptor signaling pathway | GO:0060765 | 3 | 0.918 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.917 | |
| nephron development | GO:0072006 | 109 | 0.916 | |
| ovarian follicle development | GO:0001541 | 40 | 0.915 | |
| cellular response to follicle stimulating hormone stimulus | GO:0071372 | 1 | 0.911 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.910 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.905 | |
| response to growth factor | GO:0070848 | 198 | 0.904 | |
| camp metabolic process | GO:0046058 | 40 | 0.903 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.902 | |
| angiogenesis | GO:0001525 | 201 | 0.901 | |
| peptide transport | GO:0015833 | 133 | 0.899 | |
| canonical wnt signaling pathway involved in metanephric kidney development | GO:0061290 | 2 | 0.897 | |
| regulation of camp biosynthetic process | GO:0030817 | 25 | 0.896 | |
| positive regulation of intracellular estrogen receptor signaling pathway | GO:0033148 | 4 | 0.891 | |
| succinate metabolic process | GO:0006105 | 4 | 0.890 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.889 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.887 | |
| organ growth | GO:0035265 | 117 | 0.885 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.882 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.882 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.881 | |
| androgen metabolic process | GO:0008209 | 11 | 0.880 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.878 | |
| sertoli cell differentiation | GO:0060008 | 18 | 0.877 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.877 | |
| kidney epithelium development | GO:0072073 | 121 | 0.871 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.867 | |
| taurine metabolic process | GO:0019530 | 4 | 0.866 | |
| metanephros development | GO:0001656 | 79 | 0.861 | |
| prostate gland epithelium morphogenesis | GO:0060740 | 31 | 0.860 | |
| cell proliferation in hindbrain | GO:0021534 | 10 | 0.859 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.858 | |
| progesterone metabolic process | GO:0042448 | 4 | 0.857 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.852 | |
| regulation of secretion | GO:0051046 | 274 | 0.850 | |
| regulation of triglyceride metabolic process | GO:0090207 | 17 | 0.849 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.846 | |
| prostate gland growth | GO:0060736 | 13 | 0.845 | |
| positive regulation of cyclic nucleotide metabolic process | GO:0030801 | 24 | 0.845 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.844 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.844 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.843 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.841 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.837 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.833 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.830 | |
| cell proliferation involved in kidney development | GO:0072111 | 14 | 0.830 | |
| response to peptide | GO:1901652 | 136 | 0.830 | Rat |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.828 | |
| valine metabolic process | GO:0006573 | 4 | 0.826 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.825 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.825 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.819 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.814 | Human |
| positive regulation of growth | GO:0045927 | 104 | 0.813 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.813 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.812 | |
| oxidation reduction process | GO:0055114 | 342 | 0.810 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.807 | Rat |
| t cell differentiation | GO:0030217 | 174 | 0.801 | |
| neuron projection guidance | GO:0097485 | 141 | 0.798 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.795 | |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.794 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.787 | |
| forebrain development | GO:0030900 | 302 | 0.787 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.786 | |
| development of secondary male sexual characteristics | GO:0046544 | 3 | 0.785 | |
| cell differentiation involved in kidney development | GO:0061005 | 33 | 0.785 | |
| genitalia development | GO:0048806 | 37 | 0.785 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 29 | 0.783 | |
| male gamete generation | GO:0048232 | 285 | 0.783 | |
| blood circulation | GO:0008015 | 195 | 0.782 | |
| isoleucine metabolic process | GO:0006549 | 4 | 0.780 | |
| prostate epithelial cord elongation | GO:0060523 | 3 | 0.779 | |
| glomerulus development | GO:0032835 | 40 | 0.775 | |
| regulation of system process | GO:0044057 | 200 | 0.774 | |
| ureteric bud development | GO:0001657 | 94 | 0.774 | |
| axonogenesis | GO:0007409 | 274 | 0.770 | |
| trophectodermal cellular morphogenesis | GO:0001831 | 3 | 0.769 | |
| positive regulation of immature t cell proliferation | GO:0033091 | 4 | 0.769 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.766 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.761 | |
| nuclear transport | GO:0051169 | 139 | 0.759 | |
| regulation of purine nucleotide biosynthetic process | GO:1900371 | 34 | 0.756 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.754 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.752 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.737 | |
| negative regulation of systemic arterial blood pressure | GO:0003085 | 15 | 0.732 | |
| regionalization | GO:0003002 | 337 | 0.731 | |
| hormone secretion | GO:0046879 | 128 | 0.730 | |
| nephron tubule development | GO:0072080 | 84 | 0.729 | |
| odontogenesis | GO:0042476 | 78 | 0.727 | |
| trophectodermal cell proliferation | GO:0001834 | 2 | 0.724 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.721 | |
| regulation of vasoconstriction | GO:0019229 | 14 | 0.720 | |
| cell cell signaling involved in metanephros development | GO:0072204 | 2 | 0.715 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.715 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.711 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.708 | |
| prolactin signaling pathway | GO:0038161 | 5 | 0.706 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.705 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.702 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.701 | |
| regulation of cyclic nucleotide biosynthetic process | GO:0030802 | 31 | 0.700 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.699 | |
| response to nutrient levels | GO:0031667 | 109 | 0.699 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.698 | |
| axon guidance | GO:0007411 | 141 | 0.695 | |
| regulation of tube size | GO:0035150 | 57 | 0.694 | |
| metanephric nephron development | GO:0072210 | 34 | 0.693 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.692 | |
| stem cell development | GO:0048864 | 219 | 0.691 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.689 | Human |
| protein localization to organelle | GO:0033365 | 185 | 0.687 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.686 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.685 | Human |
| immune effector process | GO:0002252 | 321 | 0.681 | |
| skeletal system development | GO:0001501 | 356 | 0.679 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.679 | |
| ossification | GO:0001503 | 216 | 0.677 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.676 | |
| response to steroid hormone | GO:0048545 | 56 | 0.676 | |
| intracellular protein transport | GO:0006886 | 204 | 0.673 | |
| regulation of steroid hormone biosynthetic process | GO:0090030 | 4 | 0.672 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.670 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.670 | |
| response to fibroblast growth factor | GO:0071774 | 47 | 0.669 | |
| adenylate cyclase inhibiting g protein coupled receptor signaling pathway | GO:0007193 | 20 | 0.669 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.668 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.667 | |
| regulation of protein transport | GO:0051223 | 163 | 0.665 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.658 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 9 | 0.656 | |
| ovulation cycle | GO:0042698 | 59 | 0.656 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.649 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.646 | |
| stem cell proliferation | GO:0072089 | 117 | 0.643 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.639 | |
| cell cell signaling involved in kidney development | GO:0060995 | 2 | 0.635 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.634 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.634 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.632 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.630 | |
| cellular water homeostasis | GO:0009992 | 2 | 0.630 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.629 | |
| response to radiation | GO:0009314 | 165 | 0.627 | |
| regulation of female gonad development | GO:2000194 | 7 | 0.626 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.625 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.615 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.613 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.611 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.610 | |
| prostatic bud formation | GO:0060513 | 10 | 0.609 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.604 | |
| exocrine system development | GO:0035272 | 45 | 0.604 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.603 | |
| oocyte maturation | GO:0001556 | 18 | 0.602 | |
| osteoblast development | GO:0002076 | 17 | 0.602 | |
| cellular response to x ray | GO:0071481 | 2 | 0.601 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.599 | |
| cell differentiation involved in metanephros development | GO:0072202 | 12 | 0.597 | |
| allantoin metabolic process | GO:0000255 | 3 | 0.595 | |
| t cell activation | GO:0042110 | 289 | 0.590 | |
| mammary gland branching involved in pregnancy | GO:0060745 | 6 | 0.589 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.588 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.586 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.583 | |
| sertoli cell development | GO:0060009 | 15 | 0.582 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.580 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.579 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.578 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.576 | |
| ear development | GO:0043583 | 200 | 0.571 | |
| cellular lactam metabolic process | GO:0072338 | 3 | 0.567 | |
| branching involved in salivary gland morphogenesis | GO:0060445 | 26 | 0.567 | |
| chromatin modification | GO:0016568 | 187 | 0.563 | |
| glucocorticoid mediated signaling pathway | GO:0043402 | 3 | 0.557 | |
| cerebellum development | GO:0021549 | 77 | 0.551 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.550 | |
| negative regulation of mesenchymal cell apoptotic process involved in metanephros development | GO:1900212 | 4 | 0.550 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.548 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.547 | |
| positive regulation of camp biosynthetic process | GO:0030819 | 19 | 0.547 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.547 | |
| cognition | GO:0050890 | 149 | 0.543 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.539 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.539 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.539 | |
| cellular response to radiation | GO:0071478 | 28 | 0.538 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.537 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.534 | |
| cellular response to antibiotic | GO:0071236 | 4 | 0.534 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.533 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.533 | |
| ovulation from ovarian follicle | GO:0001542 | 9 | 0.533 | |
| connective tissue development | GO:0061448 | 179 | 0.533 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.531 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 3 | 0.531 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.530 | |
| calcium ion transport | GO:0006816 | 159 | 0.528 | |
| germ cell development | GO:0007281 | 185 | 0.527 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.526 | |
| nephron epithelium development | GO:0072009 | 92 | 0.520 | |
| negative regulation of cellular response to insulin stimulus | GO:1900077 | 16 | 0.519 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.518 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.517 | |
| hindbrain development | GO:0030902 | 128 | 0.515 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.514 | Human |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.514 | |
| positive regulation of t cell differentiation | GO:0045582 | 52 | 0.513 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.512 | |
| locomotory behavior | GO:0007626 | 195 | 0.511 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.509 | |
| long term synaptic potentiation | GO:0060291 | 25 | 0.502 | |
| citrate metabolic process | GO:0006101 | 3 | 0.496 | |
| type i pneumocyte differentiation | GO:0060509 | 7 | 0.495 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.492 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.490 | |
| female gamete generation | GO:0007292 | 74 | 0.490 | |
| g protein coupled receptor internalization | GO:0002031 | 3 | 0.490 | |
| axon extension involved in axon guidance | GO:0048846 | 14 | 0.490 | |
| amide transport | GO:0042886 | 138 | 0.489 | |
| muscle tissue development | GO:0060537 | 308 | 0.489 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.488 | |
| negative regulation of bone resorption | GO:0045779 | 6 | 0.481 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.481 | |
| glial cell differentiation | GO:0010001 | 131 | 0.480 | |
| metanephric tubule development | GO:0072170 | 18 | 0.479 | |
| metanephric mesenchyme development | GO:0072075 | 10 | 0.479 | |
| luteinization | GO:0001553 | 8 | 0.476 | |
| endocrine system development | GO:0035270 | 98 | 0.474 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.474 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.473 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.473 | |
| appendage development | GO:0048736 | 166 | 0.471 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.471 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.469 | |
| epithelial cell proliferation involved in mammary gland duct elongation | GO:0060750 | 5 | 0.468 | |
| negative regulation of reproductive process | GO:2000242 | 31 | 0.467 | |
| androgen receptor signaling pathway | GO:0030521 | 8 | 0.466 | |
| regulation of long term synaptic potentiation | GO:1900271 | 4 | 0.466 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.465 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.465 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.462 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.455 | Human |
| regulation of epithelial cell proliferation involved in prostate gland development | GO:0060768 | 10 | 0.455 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.453 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.451 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.450 | |
| microtubule polymerization or depolymerization | GO:0031109 | 26 | 0.450 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.450 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.450 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.449 | |
| regulation of mesenchymal cell proliferation | GO:0010464 | 37 | 0.447 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.445 | |
| positive regulation of branching involved in ureteric bud morphogenesis | GO:0090190 | 18 | 0.445 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.443 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.441 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.439 | |
| dicarboxylic acid metabolic process | GO:0043648 | 18 | 0.438 | |
| digestive tract development | GO:0048565 | 190 | 0.438 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.438 | |
| regulation of microtubule polymerization | GO:0031113 | 7 | 0.435 | |
| metencephalon development | GO:0022037 | 89 | 0.432 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.432 | |
| regulation of the force of heart contraction | GO:0002026 | 17 | 0.431 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.431 | |
| camera type eye development | GO:0043010 | 266 | 0.430 | |
| harderian gland development | GO:0070384 | 2 | 0.430 | |
| prostate gland morphogenetic growth | GO:0060737 | 4 | 0.428 | |
| follicle stimulating hormone secretion | GO:0046884 | 1 | 0.428 | |
| negative regulation of androgen receptor signaling pathway | GO:0060766 | 3 | 0.428 | |
| hippocampus development | GO:0021766 | 52 | 0.427 | |
| regulation of kidney development | GO:0090183 | 40 | 0.426 | |
| regulation of mesonephros development | GO:0061217 | 24 | 0.425 | |
| lipid localization | GO:0010876 | 126 | 0.425 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.425 | |
| inositol phosphate biosynthetic process | GO:0032958 | 6 | 0.424 | |
| regulation of mesenchymal cell apoptotic process involved in metanephros development | GO:1900211 | 4 | 0.421 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.418 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.417 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.416 | |
| regulation of microtubule polymerization or depolymerization | GO:0031110 | 20 | 0.415 | |
| mesonephros development | GO:0001823 | 97 | 0.414 | |
| cellular response to lipid | GO:0071396 | 145 | 0.412 | |
| lactation | GO:0007595 | 25 | 0.411 | |
| female genitalia development | GO:0030540 | 14 | 0.409 | |
| maternal process involved in female pregnancy | GO:0060135 | 32 | 0.408 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.407 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.406 | |
| regulation of transcription factor import into nucleus | GO:0042990 | 24 | 0.406 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.405 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.405 | |
| response to insulin | GO:0032868 | 100 | 0.403 | Rat |
| positive regulation of adenylate cyclase activity | GO:0045762 | 8 | 0.403 | |
| acetate ester metabolic process | GO:1900619 | 3 | 0.402 | |
| lateral line system development | GO:0048925 | 1 | 0.401 | |
| response to tumor necrosis factor | GO:0034612 | 26 | 0.399 | |
| leydig cell differentiation | GO:0033327 | 10 | 0.398 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.397 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.397 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.397 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.396 | |
| single organism nuclear import | GO:1902593 | 95 | 0.395 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.395 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.394 | |
| somite development | GO:0061053 | 81 | 0.394 | |
| protein targeting | GO:0006605 | 143 | 0.393 | |
| salivary gland development | GO:0007431 | 37 | 0.392 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.386 | |
| bone development | GO:0060348 | 120 | 0.384 | |
| segmentation | GO:0035282 | 93 | 0.383 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.383 | |
| spinal cord development | GO:0021510 | 81 | 0.382 | |
| negative regulation of bone remodeling | GO:0046851 | 6 | 0.381 | |
| response to ketone | GO:1901654 | 15 | 0.380 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.378 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.377 | |
| response to oxygen levels | GO:0070482 | 62 | 0.377 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.375 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.375 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.371 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.370 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.368 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.367 | |
| cartilage development | GO:0051216 | 140 | 0.367 | |
| hair follicle development | GO:0001942 | 85 | 0.367 | |
| memory | GO:0007613 | 58 | 0.365 | |
| regulation of acetylcholine metabolic process | GO:0060408 | 1 | 0.365 | |
| adult behavior | GO:0030534 | 135 | 0.364 | |
| positive regulation of endothelial cell proliferation | GO:0001938 | 17 | 0.364 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.362 | |
| regulation of fatty acid oxidation | GO:0046320 | 10 | 0.362 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.361 | |
| positive regulation of inositol trisphosphate biosynthetic process | GO:0032962 | 2 | 0.356 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.356 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.355 | |
| response to granulocyte macrophage colony stimulating factor | GO:0097012 | 3 | 0.355 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.354 | |
| mammary gland alveolus development | GO:0060749 | 22 | 0.352 | |
| retinal ganglion cell axon guidance | GO:0031290 | 18 | 0.352 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.351 | |
| spermatogenesis exchange of chromosomal proteins | GO:0035093 | 4 | 0.351 | |
| muscle hypertrophy | GO:0014896 | 24 | 0.350 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.349 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.348 | |
| cation transport | GO:0006812 | 399 | 0.347 | |
| positive regulation of purine nucleotide biosynthetic process | GO:1900373 | 26 | 0.346 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.345 | |
| cellular response to peptide | GO:1901653 | 92 | 0.345 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.345 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.344 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.344 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.343 | |
| sertoli cell proliferation | GO:0060011 | 5 | 0.341 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.340 | |
| sensory perception | GO:0007600 | 245 | 0.339 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.338 | |
| inflammatory response | GO:0006954 | 244 | 0.337 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.336 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.336 | |
| amine metabolic process | GO:0009308 | 45 | 0.335 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.334 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.333 | |
| response to corticosterone | GO:0051412 | 1 | 0.332 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.332 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.331 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.330 | |
| positive regulation of alpha beta t cell differentiation | GO:0046638 | 28 | 0.328 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.328 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.328 | |
| salivary gland morphogenesis | GO:0007435 | 33 | 0.327 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.327 | |
| nuclear import | GO:0051170 | 95 | 0.327 | |
| response to vitamin d | GO:0033280 | 3 | 0.326 | |
| response to drug | GO:0042493 | 75 | 0.325 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.323 | |
| drug catabolic process | GO:0042737 | 2 | 0.323 | |
| metanephros morphogenesis | GO:0003338 | 24 | 0.322 | |
| response to ammonium ion | GO:0060359 | 21 | 0.321 | |
| spermatid differentiation | GO:0048515 | 115 | 0.320 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.320 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.320 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.320 | |
| lipid transport | GO:0006869 | 98 | 0.319 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.319 | |
| polyol biosynthetic process | GO:0046173 | 13 | 0.319 | |
| peptide secretion | GO:0002790 | 114 | 0.319 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.317 | |
| response to interleukin 15 | GO:0070672 | 3 | 0.314 | |
| regulation of nitrogen cycle metabolic process | GO:1903314 | 1 | 0.313 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.312 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.312 | |
| lung epithelium development | GO:0060428 | 37 | 0.312 | |
| metanephric glomerular epithelium development | GO:0072244 | 3 | 0.312 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.311 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.311 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.311 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.309 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.308 | |
| cell growth | GO:0016049 | 130 | 0.307 | |
| neuropeptide signaling pathway | GO:0007218 | 19 | 0.306 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.305 | |
| prostate gland morphogenesis | GO:0060512 | 32 | 0.304 | |
| positive t cell selection | GO:0043368 | 23 | 0.304 | |
| regulation of protein localization | GO:0032880 | 231 | 0.304 | Human |
| male genitalia development | GO:0030539 | 20 | 0.303 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.303 | |
| cation homeostasis | GO:0055080 | 212 | 0.303 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.302 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.302 | |
| inner ear receptor cell differentiation | GO:0060113 | 61 | 0.301 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.301 | |
| positive regulation of heart growth | GO:0060421 | 18 | 0.300 | |
| body fluid secretion | GO:0007589 | 53 | 0.296 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.294 | |
| metanephric nephron epithelium development | GO:0072243 | 19 | 0.294 | |
| regulation of alpha beta t cell differentiation | GO:0046637 | 35 | 0.294 | |
| regulation of toll like receptor signaling pathway | GO:0034121 | 20 | 0.294 | |
| negative regulation of kidney development | GO:0090185 | 15 | 0.293 | |
| cranial nerve structural organization | GO:0021604 | 13 | 0.292 | |
| response to cocaine | GO:0042220 | 14 | 0.292 | |
| water homeostasis | GO:0030104 | 27 | 0.290 | |
| vasoconstriction | GO:0042310 | 27 | 0.288 | |
| response to corticosteroid | GO:0031960 | 20 | 0.287 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.287 | |
| cellular homeostasis | GO:0019725 | 240 | 0.286 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.281 | |
| epithelial cell differentiation involved in kidney development | GO:0035850 | 23 | 0.281 | |
